Tag : AI

CONFERENCE UPDATE

AI-assisted screening detects early-stage lung cancer in high-risk never-smokers: Interim results from the local LC-SHIELD study
In East Asia, nearly half of lung cancer patients are never-smokers. The LC-SHIELD study explores AI-driven nodule detection, showing feasibility and improved sensitivity and specificity for high-risk populations.
CONFERENCE UPDATE

From hospital to home: Uberizing the future of PD care
Professor Goh Bak Leong

Senior Consultant Nephrologist, Universiti Tunku Abdul Rahman, Selangor, Malaysia
NEWS AND PERSPECTIVE

HKUMed unveils AI model achieving over 90% accuracy in thyroid cancer diagnosis
Psoriasis is a chronic inflammatory disorder characterized by systemic inflammation and elevated circulating levels of pro-inflammatory cytokines. This persistent inflammatory state has been implicated in immune-mediated injury across multiple organ systems, with particular involvement of renal tissues. However, few large-scale studies have evaluated whether psoriasis independently increases the risk of renal complications in type 2 diabetes mellitus (T2DM) patients receiving guideline-directed renoprotective therapies. A retrospective cohort study was performed by researchers in Texas to compare the risk of diabetic nephropathy, chronic kidney disease (CKD), end-stage renal disease (ESRD), and dialysis in T2DM patients with and without psoriasis who were receiving angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB) or sodium-glucose cotransporter-2 inhibitor (SGLT2i) therapies.